Provided by Tiger Trade Technology Pte. Ltd.

AMPLIA THERAPEUTICS LTD

0.120
-0.005-4.00%
Volume:236.05K
Turnover:29.36K
Market Cap:61.57M
PE:-5.95
High:0.125
Open:0.125
Low:0.120
Close:0.125
52wk High:0.425
52wk Low:0.049
Shares:513.07M
Float Shares:351.32M
Volume Ratio:0.50
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.020
EPS(LYR):-0.021
ROE:-28.49%
ROA:-17.71%
PB:1.43
PE(LYR):-5.61

Loading ...

Company Profile

Company Name:
AMPLIA THERAPEUTICS LTD
Exchange:
ASX
Establishment Date:
2000
Employees:
- -
Office Location:
90 William Street,Level 5,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9473 2555
Introduction:
Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.